Birch Hill Investment Advisors LLC Abbott Laboratories Transaction History

Birch Hill Investment Advisors LLC

$2.02 Billion
Q1 2025

A detailed history of Birch Hill Investment Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Birch Hill Investment Advisors LLC holds 26,110 shares of ABT stock, worth $3.45 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

26,110

Previous 26,243 0.51%

Holding current value

$3.45 Million

Previous $2.97 Million 16.68%

% of portfolio

0.17%

Previous 0.14%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 18, 2025	SELL	$111.1 - $140.22 $14,776 - $18,649	-133 Reduced 0.51%	26,110 $3.46 Million
Q4 2024 Jan 28, 2025	SELL	$111.93 - $119.39 $13,431 - $14,326	-120 Reduced 0.46%	26,243 $2.97 Million
Q3 2024 Oct 10, 2024	SELL	$100.07 - $118.13 $150,105 - $177,195	-1,500 Reduced 5.38%	26,363 $3.01 Million
Q2 2024 Jul 30, 2024	SELL	$100.73 - $112.44 $114,630 - $127,956	-1,138 Reduced 3.92%	27,863 $2.9 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $41,179 - $45,480	-376 Reduced 1.28%	29,001 $3.3 Million
Q4 2023 Jan 29, 2024	BUY	$90.19 - $110.4 $185,069 - $226,540	2,052 Added 7.51%	29,377 $3.23 Million
Q3 2023 Oct 19, 2023	SELL	$95.53 - $114.62 $34,390 - $41,263	-360 Reduced 1.3%	27,325 $2.65 Million
Q2 2023 Jul 20, 2023	BUY	$100.78 - $112.29 $29,226 - $32,564	290 Added 1.06%	27,685 $3.02 Million
Q1 2023 Apr 14, 2023	SELL	$96.86 - $114.01 $257,550 - $303,152	-2,659 Reduced 8.85%	27,395 $2.77 Million
Q3 2022 Oct 19, 2022	SELL	$96.76 - $112.03 $4,838 - $5,601	-50 Reduced 0.17%	30,054 $2.91 Million
Q2 2022 Jul 13, 2022	SELL	$102.07 - $123.37 $35,724 - $43,179	-350 Reduced 1.15%	30,104 $3.27 Million
Q1 2022 Apr 08, 2022	SELL	$114.02 - $139.04 $265,096 - $323,268	-2,325 Reduced 7.09%	30,454 $3.61 Million
Q4 2021 Feb 02, 2022	SELL	$115.53 - $141.46 $23,106 - $28,292	-200 Reduced 0.61%	32,779 $4.61 Million
Q3 2021 Oct 25, 2021	SELL	$116.66 - $129.06 $52,497 - $58,077	-450 Reduced 1.35%	32,979 $3.9 Million
Q2 2021 Jul 22, 2021	SELL	$105.79 - $124.53 $18,513 - $21,792	-175 Reduced 0.52%	33,429 $3.88 Million
Q1 2021 Apr 26, 2021	SELL	$108.84 - $128.23 $138,771 - $163,493	-1,275 Reduced 3.66%	33,604 $4.03 Million
Q4 2020 Jan 27, 2021	BUY	$105.0 - $114.42 $262,500 - $286,050	2,500 Added 7.72%	34,879 $3.82 Million
Q3 2020 Oct 22, 2020	SELL	$91.64 - $111.29 $22,910 - $27,822	-250 Reduced 0.77%	32,379 $3.52 Million
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $11,485 - $14,700	150 Added 0.46%	32,629 $2.98 Million
Q4 2019 Jan 17, 2020	SELL	$78.51 - $87.4 $52,994 - $58,995	-675 Reduced 2.04%	32,479 $2.82 Million
Q3 2019 Oct 16, 2019	SELL	$81.84 - $88.74 $136,509 - $148,018	-1,668 Reduced 4.79%	33,154 $2.77 Million
Q2 2019 Jul 22, 2019	SELL	$72.88 - $85.0 $3,644 - $4,250	-50 Reduced 0.14%	34,822 $2.93 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $177,668 - $214,800	-2,683 Reduced 7.14%	34,872 $2.79 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $70,477 - $79,840	-1,075 Reduced 2.78%	37,555 $2.72 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $165,099 - $199,172	2,715 Added 7.56%	38,630 $2.83 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $314,677 - $347,309	5,466 Added 17.95%	35,915 $2.19 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $596,124 - $673,990	10,594 Added 53.36%	30,449 $1.83 Million
Q4 2017 Feb 09, 2018	SELL	$53.68 - $57.47 $64,416 - $68,964	-1,200 Reduced 5.7%	19,855 $1.13 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $48 - $53	-1 Reduced -0.0%	21,055 $1.12 Million
Q2 2017 Aug 11, 2017	BUY	N/A	21,056	21,056 $1.02 Million

Others Institutions Holding ABT

# of Institutions

3,519

Shares Held

1.38B

Call Options Held

10.1M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $231B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Birch Hill Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Birch Hill Investment Advisors LLC with notifications on news.

Account

Birch Hill Investment Advisors LLC Abbott Laboratories Transaction History